Contraception for women taking antiepileptic drugs

Journal of Family Planning and Reproductive Health Care

Volumn 36, Issue 4, 2010, Pages 239-242

  O'Brien, Michael D ^a   Guillebaud, John ^b  

^a GUY S HOSPITAL   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Antiepileptic drugs; Contraception; Epilepsy; Liver enzyme induction; Women

Indexed keywords

ACETAZOLAMIDE; ANTICONVULSIVE AGENT; CARBAMAZEPINE; CLONAZEPAM; CONTRACEPTIVE AGENT; COPPER INTRAUTERINE DEVICE; CYTOCHROME P450; DESOGESTREL; ELLAONE; ETHINYLESTRADIOL; ETHINYLESTRADIOL PLUS ETONOGESTREL; ETHINYLESTRADIOL PLUS LEVONORGESTREL; ETHINYLESTRADIOL PLUS NORELGESTROMIN; ETHINYLESTRADIOL PLUS NORETHISTERONE ACETATE; ETHOSUXIMIDE; ETONOGESTREL; FELBAMATE; GESTAGEN; LAMOTRIGINE; LEVONELLE; LEVONORGESTREL; LIVER ENZYME; MEDROXYPROGESTERONE ACETATE; MESTRANOL PLUS NORETHISTERONE; OXCARBAZEPINE; PHENYTOIN; POSTCOITUS CONTRACEPTIVE AGENT; PRIMIDONE; RUFINAMIDE; TOPIRAMATE; ULIPRISTAL ACETATE; UNCLASSIFIED DRUG; UNINDEXED DRUG;

BLEEDING; CHRONIC PAIN; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG DOSE INCREASE; DRUG METABOLISM; DRUG SAFETY; EMERGENCY CONTRACEPTION; ENZYME INDUCTION; ENZYME INHIBITION; GLUCURONIDATION; HORMONAL CONTRACEPTION; HUMAN; MIGRAINE; OVULATION INHIBITION; PUERPERIUM; REVIEW; VAGINA RING;

EID: 78149340111     PISSN: 14711893     EISSN: None     Source Type: Journal    
DOI: 10.1783/147118910793048764     Document Type: Review

References (24)

1. Jean-Jacques A. Contraception for women: an evidence based overview. BMJ 2009; 339: 563-568.
2. Clinical Effectiveness Unit of the Faculty of Family Planning and Reproductive Health. Use of contraception outside terms of the product licence. J Fam Plann Reprod Health Care 2005; 31: 225-242.
3. Garnett WR. Clinical pharmacology of topiramate: a review. Epilepsia 2000; 41(Suppl. 1): 61-65.
4. Herzog AG, Farina EL, Blum AS. Serum valproate levels with oral contraceptive use. Epilepsia 2005; 46: 970-971.
5. Galimberti CA, Mazzucchelli I, Arbasino C, Canevini MP, Fattore C, Perucca E. Increased apparent oral clearance of valproic acid during intake of combined contraceptive steroids in women with epilepsy. Epilepsia 2006; 47: 1569-1572. (Pubitemid 44393871)
6. Schwenkhagen AM, Stodieck SRG Which contraception for women with epilepsy? Seizure 2008; 17: 145-150.
7. Faculty of Family Planning and Reproductive Health. Drug interactions with hormonal contraception. J Fam Plann Reprod Health Care 2005; 31: 139-151.
8. Milsom I, Korver T. Ovulation incidence with oral contraceptives: a literature review. J Fam Plann Reprod Health Care 2008; 34: 237-246.
9. Guillebaud J. Drug interactions with hormonal contraception. J Fam Plann Reprod Health Care 2005; 31: 335-336.
10. Szarewski A. Sisters doing it for themselves J Fam Plann Reprod Health Care 2009; 35: 71-72.
11. Canadian consensus guideline on continuous and extended hormonal contraception. J Obstet Gyn Can 2007; 29(7 Suppl. 2): S1-S32.
12. Rice C, Killick S, Dieben T, Coelingh Bennink H. A comparison of the inhibition of ovulation achieved by desogestrel 75 meg and levonorgestrel 30 mcg daily. Hum Reprod 1999; 14: 982-985. (Pubitemid 29176478)
13. Timmer CJ, Srivastava N, Dieben TO, Cohen AF. Bioavailability and bioequivalence of etonogestrel from two oral formulations of desogestrel: Cerazette® and Liseta®. Eur J Drug Metab Pharmacokinet 1999; 24: 335-343.
14. Graesslin O, Korver T. The contraceptive efficacy of Implanon®: a review of clinical trials and marketing experience. Eur J Contracept Reprod Health Care 2008; 13(Suppl. 1): 4-12.
15. Faculty of Family Planning and Reproductive Health Care Clinical Effectiveness Unit. Faculty Statement from the CEU on Levonelle® 1500 mg and the Use of Liver Enzyme Inducing Drugs. 2005. http://www.fsrh.org/admin/ uploads/563-Levonelle1500KeyStatement.pdf [Accessed 15 March 2010].
16. Mansour D. EllaOne®: a second-generation emergency contraceptive? J Fam Plann Reprod Health Care 2009; 35: 217-218.
17. Glasier AF, Cameron ST, Fine PM, Logan SJS, Casale W, van Hom J, et al. Ulipristal acetate versus levonorgestrel for emergency contraception. Lancet 2010; 375: 555-562.
18. HRA Pharma UK. Depo-Provera 150mg/ml Injection: Summary of Product Characteristics. 2009. http://emc.medicines.org.uk/medicine/11121/SPC/Depo- Provera+150mg+ml+Injection/ [Accessed 15 March 2010].
19. Gupta C, Osterman J, Santen R, Bardin CW. In vivo metabolism of progestins. V. The effect of protocol design on the estimated metabolic clearance rate and volume of distribution of medroxyprogesterone acetate in women. J Clin Endocrinol Metab 1979; 48: 816-620.
20. Faculty of Family Planning and Reproductive Health Care. Statement on MHRA Guidance on DMPA. 18 November 2004. http://www.fsrh.org/admin/uploads/Depo- Provera-alert-statement.pdf [Accessed 15 March 2010].
21. Bounds W, Guillebaud J. Observational series on women using contraceptive Mirena concurrently with anti-epileptic and other enzyme-inducing drugs. J Fam Plann Reprod Health Care 2002; 28: 78-80.
22. Faculty of Family Planning and Reproductive Health Care Clinical Effectiveness Unit. Faculty Statement from the CEU on Changes to Prescribing Information for Lamotrigine. 2005. http://www.fsrh.org/admin/uploads/archive/ lamotrigine05.pdf [Accessed 15 March 2010].
23. Sabers A, Ohman I, Christensen J, Tomson T. Oral contraceptives reduce lamotrigine plasma levels. Neurology 2003; 61: 570-571. (Pubitemid 37025386)
24. Sidhu J, Job S, Singh S, Philipson R, The pharmacokinetic and pharmacodynamic consequences of the co-administration of lamotrigine and a combined oral contraceptive in healthy female subjects. Br J Clin Pharmacol 2006; 61: 191-199.